Odontogenic tumours includes broad spectrum of lesions derived from specialized dental tissues. Neoplasms and tumours related to the odontogenic apparatus may be composed only of epithelial tissue or epithelial tissue associated with odontogenic ectomesenchyme. They constitute abortive attempt at odontogenesis. Odontogenic tumors can be intraosseous or extraosseous with varying clinical and radiographic features. Odontogenic tumours are associated with molecular and genetic alterations. This review presents outline of molecular and genetic alterations associated with nature and growth of benign odontogenic tumours.
INTRODUCTION
Pathologies of the tooth forming apparatus comprise of epithelial, ectomesenchymal, and/or mesenchymal elements, that give rise to odontogenic tumors. Odontogenic tumors can be Ddental hamartomas, benign or malignant tumors. These tumors, therefore, are found exclusively within jaw bones or in the soft mucosal tissue overlying the tooth-bearing areas. The progress in the field of molecular pathology has brought the remarkable change in the practice of pathology. Many studies have been done from biochemistry to molecular biology, and this gave rise to various tumor markers.
According to the National Cancer Institute (2008), "Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (non-cancerous) conditions. These substances can be found in the blood, in the urine, in the tumor tissue, or in othertissues."
1 Different tumor markers are found in different cancers and levels of the same tumor marker can be altered in more than one type of cancer. CD10, matrix metalloproteinases, cytokeratins, vimentins are few tumor markers. 2 Modern pathology has integrated tumor markers. So this article reviews regarding various tumor markers in benign odontogenic lesions.
Amelogenin
Enamel matrix includes significant protein components: Amelogenins and non-amelogenins (enamelins, ameloblastins, and tuftelins) 3 . These are produced by ameloblast. Amongst enamel proteins, amelogenin are major proteins. They contain 90% extracellular matrix and play a role in the organization of enamel. The cytoplasm of the cells of the reduced enamel epithelium, stratum intermedium and stellate reticulum of the enamel organ demonstrated amelogenin. 4 Odontogenic tumors contain odontogenic epithelium. Studies suggest that aberrated enamel proteins are seen in oncogenesis. Anigol et al. studied amelogenin expression in odontogenic cysts and tumors. According to them, amelogenin expression was positive in the dentigerous cyst, radicular cyst, odontogenic keratocyst (OKC), ameloblastoma, squamous odontogenic tumor, adenomatoid odontogenic tumor (AOT), calcifying epithelial odontogenic tumor (CEOT), odontomas and ameloblastic carcinoma. 5 They concluded that amelogenin molecule could be used as a marker for odontogenic lesions and odontogenic epithelium especially when there is difficulty in a demonstration of the same in routine hematoxylin and eosin stains. 5 
Tenascin
Extracellular matrix glycoprotein regulating cell morphology is tenascin. It is commonly expressed during epithelial-mesenchymal interaction during tooth development. Similarly, the stromal e xpression is seen in carcinomas and epithelialmesenchymal interaction during carcinogenesis. 8 Previous studies suggest that tenascin was localised in human teeth during epithelial bud formation. It was seen in the basement membrane during odontoblast differentiation. Tenascin was not seen in dentine as dental papilla cells stop expressing on differentiating into dentin. The unusual expression of tenascin in dental mesenchymal cells shows its capacity to differentiate into hard tissue forming cells. 9,10 Nagai et al. studied the expression of tenascin in ameloblastomas, ameloblastic fibromas, ameloblastic carcinomas and tooth germs using monoclonal antibodies. 8 Tenascin expression was observed in the dental papilla under the basement membrane, pre-odontoblastic layer and negative in a dental follicle. In ameloblastic fibroma, the basement membrane and stroma showed high tenascin expression. In follicular ameloblastoma, irregular linear tenascin positive reaction was observed in the basement membrane zone. In ameloblastic carcinomas, stroma and basement membrane showed an irregular strong reaction. They concluded that tenascin can be used as a marker in the epithelialmesenchymal interaction during tooth development and in odontogenic tumors.
11

Bone Morphogenetic Proteins
Cytokine transforming growth factor beta superfamily includes bone morphogenetic protein. Bone morphogenetic protein is observed in bone and dentin matrix. It has the ability to induce bone formation. 12 Previous literature suggests that bmp 2, 4, 7 can be expressed within the enamel knot which acts as signaling center. 13 Gao et al. studied the expression of bone morphogenetic proteins in 44 cases of odontogenic tumors consisting of 20 ameloblastomas, eight cementifying fibromas, five benign cementoblastomas, three dentinomas and two cases of compound odontomas, adenomatoid odontogenic tumors, calcifying epithelial odontogenic, and odontogenic fibromas. They classified odontogenic tumors according to the expression observed. Positive expression was observed in all cementifying fibromas, benign cementoblastomas, dentinomas, odontogenic fibromas, and compound odontomas whereas all ameloblastomas, adenomatoid odontogenic tumors, and calcifying epithelial odontogenic tumors were negative. They concluded that BMPMcAb-positive odontogenic tumors were those tumors with the formation of hard tissues. Although most odontogenic tumors are benign, they are locally destructive and cause significant bone destruction. Members of tumor necrosis factor superfamily cause bone remodeling. These include RANK-RANKL and osteoprotegerin (OPG). They control activation, formation, and differentiation of osteoclasts. 15 Receptor activator of NF-KB ligand is expressed by osteoblast and stromal cells. RANKL binds to its receptor RANK present on the surface of osteoclasts and precursors and differentiates osteoclasts into multinucleated cells to bring bone resorption. Osteoblast and stromal cells also secrete osteoprotegerin which binds Ra nkl and prevents bone resorption. 16 Andrade et al. studied the expression of RANK, RANKL and OPG expression in calcifying cystic odontogenic tumor (CCOT), AOT, CEOT, odontogenic myxoma (OM), and ameloblastic fibroma (AF). They observed higher expression of OPG in AOT and CCOT. On the contrary, mesenchymal cells of OM and AF expressed RANKL which was consistent with their tendency for recurrence and bone resorption.
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Matrix Metalloproteinase
The group of enzymes that bring about the degradation of extracellular matrix proteins during growth and tissue remodeling is Matrix Metalloproteinase (MMP). 18 The classification of these enzymes is based on the type of substrates like collagenase, gelatinase, stromelysin. MMP-2, also known as gelatinase, has substrates gelatin Types I to III and collagen types IV, V, VII, and X. MMP-3, also known as stromelysin degrades proteoglycans, JCD fibronectin, laminin.Bast et al. studied the expression of MMP in OM's. They observed significant expression of MMP-2 in tumor cells.They concluded that MMP-2 aids in expansion and growth of a tumor. 19 Pinheiro et al.
studied the expression of MMP in ameloblastoma using immunohistochemistry and biochemical methods. They confirmed the expression of MMP-1, MMP-2, and MMP-9 in ameloblastomas. According to Pinheiro et al., MMP expression was seen in peripheral columnar cells, bone neoplasm interface, in stromal regions and bone. The secretion of MMP is either through ameloblastoma cells or induction by stromal cells. MMP's releases mitogens from bone by causing its resorption and matrix solubilization. These mitogens further increase cellular proliferation rate of ameloblastoma in a cord like fashion.
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Collagen IV a1 to a6 Chains Type IV collagen is a major component of the basement membrane. It is a triple helical molecule consisting of three a-chains. They are divided as a1-like class composed of a1 (IV), a3 (IV) and a5 (IV) chains; and a2-like class composed of a2 (IV), a4 (IV) and a6 (IV).
It is encoded by six distinct genes, COL4A1 to COL4A6. During tooth development, type IV collagen exhibit specific distributionpattern. 21 Nagatsuka et al. studied the expression of anti-a (IV) chain-specific monoclonal antibodies in ameloblastomas, adenomatoid odontogenic tumors, ameloblastic fibromas, ameloblastic carcinomas, ameloblastic fibro-, and primary intraosseous carcinoma. They observed a difference between basement membranes of odontogenic neoplasms, normal oral mucosa and developing tooth germ. Amongst ameloblastomas, desmoplastic showed higher expression of a1 (IV)/a2 (IV) and a5 (IV)/a6 (IV) chains than ordinary ameloblastomas. Expression was also observed in basement membrane and tumor cells of AF and ameloblastic fibroodontosarcoma except hard tissues. In AOT, the basement membrane of cribriform areas and hyaline materials were positive, whereas weak around epithelial whorls/rose ttes/nests and mineralized foci. 22 Malignant odontogenic tumors exhibited irregular a(IV) chain profile as compared to benign odontogenic neoplasms. They exhibited higher a5 (IV)/a6 (IV) chains compared to a1 (IV)/a2 (IV) chains. They concluded that a5 (IV)/a6 (IV) chain deposition play a role in protection by offering resistance to invasion in malignant neoplasms.
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Nestin
Nestin is an intermediate filament. It is related to neurofilaments. It is expressed in muscles, developing a nervous system, bell stage of odontogenesis, functional odontoblasts. Thus, it is related to odontogenesis and dentinal repair. 23 Fujita et al. (2006) studied nestin expression in ameloblastoma, odontoma, ameloblastic fibroma, ameloblastic fibro-odontoma and fibro-dentinoma, adenomatoid odontogenic tumor, odontogenic fibroma, intra-osseous myxoma. They observed negative nestin expression in ameloblastomas. Odontogenicectomesenchyme adjacent to odontogenic epithelium in mixed odontogenic tumors exhibited positive nestin expression. In odontomas and ameloblastic fibro-odontomas, nestin expressed was observed in odontoblasts and their processes, dentinoid matrix as well as plump cells adhering to dentinoid. Half cases of myxomas and single case of odontogenic fibroma expressed nestin. In AOT, nestin expression was observed in scattered nodular, rosette arrangements as well as in whorled epithelial cells. Thus, they concluded that nestin expression is increased in ectomesenchyme of mixed odontogenic tumors on stimulation by odontogenic epithelium. Also, nesting can be seen as a marker odontoblasts in mixed odontogenic tumors .
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Bcl-2 Family Proteins in Odontogenic Tumors
Apoptosis, also known as programmed cell death, is an essential physiological process for elimination of cells. The protein family involved in apoptosis is Bcl-2. It consists of pro-apoptotic and anti-apoptotic members. Bcl-2 gene homologue, Bcl-x gene, encodes two proteins, bcl-xL and bcl-xS. Bcl-xS promotes apoptosis by inhibiting bcl-2 whereas bcl-xL has anti-apoptotic activity. 25 An additional bcl-2 homolog, bax protein promotes apoptosis by interacting with bcl-2 or bcl-xL proteins. Kumamoto 
CONCLUSION
Only a few odontogenic tumor markers are available. Tumor markers will play a significant role even though histopathology seems to be indispensable in the diagnosis of odontogenic tumors.
